Alterity Therapeutics
ATHE
11 hedge funds and large institutions have $415K invested in Alterity Therapeutics in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 4 closing their positions.
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
15% less funds holding
Funds holding: 13 → 11 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
56% less capital invested
Capital invested by funds: $952K → $415K (-$537K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$69.7K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$22.1K |
| 3 |
Morgan Stanley
New York
|
+$15.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$4.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CWM
Cornerstone Wealth Management
St. Peters,
Missouri
|
-$333K |
| 2 |
Renaissance Technologies
New York
|
-$51K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$49K |
| 4 |
OIA
Optimum Investment Advisors
Chicago,
Illinois
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $280K | +$15.8K | +911 | +4% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $96K | +$69.7K | +4,010 | +116% |
|
|
3
Citadel Advisors
Miami,
Florida
| $16K | +$22.1K | +1,274 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $13K | +$4.14K | +238 | +31% |
|
|
CA
5
Claro Advisors
Boston,
Massachusetts
| $5K | +$3.89K | +224 | New |
|
|
AG
6
Advisor Group
Phoenix,
Arizona
| $3K | – | – | – |
|
|
AIM
7
Advantage Investment Management
Cedar Rapids,
Iowa
| $1K | – | – | – |
|
|
NFG
8
Next Financial Group
Houston,
Texas
| $1K | – | – | – |
|
|
APA
9
American Portfolios Advisors
Holbrook,
New York
| $106 | – | – | – |
|
|
10
Renaissance Technologies
New York
| – | -$51K | -2,522 | Closed |
|
|
11
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$49K | -2,452 | Closed |
|
|
OIA
12
Optimum Investment Advisors
Chicago,
Illinois
| – | -$3K | -150 | Closed |
|
|
CWM
13
Cornerstone Wealth Management
St. Peters,
Missouri
| – | -$333K | -89 | Closed |
|
ATHE Hedge Fund Activity: Q4 2018 in Review
11 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q4 2018, worth a combined $415K — down 56% from $952K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ATHE and 2 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 3 added.
The largest buyer was Susquehanna International Group, adding an estimated $69.7K. The largest seller was Cornerstone Wealth Management, exiting entirely with an estimated $333K sold.
- 11 institutional investors held Alterity Therapeutics (ATHE) as of Q4 2018, down from 13 in Q3 2018.
- Funds reported $415K of Alterity Therapeutics stock for Q4 2018, down 56% quarter-over-quarter.
- 2 funds opened new Alterity Therapeutics positions in Q4 2018 and 4 closed out, a net change of -2 holders.
- The largest Alterity Therapeutics buyer in Q4 2018 was Susquehanna International Group, an estimated $69.7K added.
- The largest Alterity Therapeutics seller in Q4 2018 was Cornerstone Wealth Management, an estimated $333K sold.
Based on aggregated 13F filings for Q4 2018.